206 related articles for article (PubMed ID: 31301415)
1. E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma.
Li Y; Jiang L; Lv S; Xu H; Fan Z; He Y; Wen H
Life Sci; 2019 Sep; 232():116649. PubMed ID: 31301415
[TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
Xue Z; Zhu X; Teng Y
Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
[TBL] [Abstract][Full Text] [Related]
3. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.
Dai W; Mu L; Cui Y; Li Y; Chen P; Xie H; Wang X
Med Sci Monit; 2019 Jan; 25():730-738. PubMed ID: 30681073
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
Gao X; Du H; Zhang R; Li C; Wang H; Xuan Q; Liu D
J Cell Physiol; 2019 Jun; 234(6):9008-9018. PubMed ID: 30362539
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway.
Pei Z; Du X; Song Y; Fan L; Li F; Gao Y; Wu R; Chen Y; Li W; Zhou H; Yang Y; Zeng J
Oncotarget; 2017 Mar; 8(11):18145-18153. PubMed ID: 28199978
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis.
Liu R; Yang X
BMC Cancer; 2021 Oct; 21(1):1163. PubMed ID: 34715819
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a.
Ba Z; Gu L; Hao S; Wang X; Cheng Z; Nie G
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29194827
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
Xu DF; Wang LS; Zhou JH
Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA Hotair promotes gastric cancer progression via miR-217-GPC5 axis.
Dong X; He X; Guan A; Huang W; Jia H; Huang Y; Chen S; Zhang Z; Gao J; Wang H
Life Sci; 2019 Jan; 217():271-282. PubMed ID: 30557546
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of long non-coding RNA cancer susceptibility 2 inhibits cell invasion and angiogenesis in gastric cancer.
Zhou J; Huang H; Tong S; Huo R
Mol Med Rep; 2017 Oct; 16(4):5235-5240. PubMed ID: 28849111
[TBL] [Abstract][Full Text] [Related]
11. The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma.
Lu L; Dai Z; Luo Q; Lv G
Mol Med Rep; 2018 Jan; 17(1):1947-1953. PubMed ID: 29257211
[TBL] [Abstract][Full Text] [Related]
12. lncRNA CASC2 Enhances
Tao L; Tian P; Yang L; Guo X
Biomed Res Int; 2020; 2020():7183629. PubMed ID: 33134385
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
14. lncRNA CASC2/miR‑18a‑5p axis regulates the malignant potential of nasopharyngeal carcinoma by targeting RBBP8.
Miao WJ; Yuan DJ; Zhang GZ; Liu Q; Ma HM; Jin QQ
Oncol Rep; 2019 Mar; 41(3):1797-1806. PubMed ID: 30569153
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer.
Zhang S; Xu J; Wang H; Guo H
Cancer Biomark; 2019; 24(4):429-437. PubMed ID: 30909185
[TBL] [Abstract][Full Text] [Related]
18. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
Fan JC; Zeng F; Le YG; Xin L
J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]